Effect isradipine atenolol lung function patients mild essential hypertension Twenty-six hypertensive patients part open parallel-group pilot study effects nine-week treatment period calcium antagonist isradipine beta agent atenolol mean dosage isradipine group mg/day mg/day atenolol group significant reduction arterial blood pressure treatment Lung volumes airways resistance unchanged atenolol-treated group linear relationship alveolar pressure resistance lung volumes expiration forced vital capacity shift airways resistance change early sign altered air-flow behavior small airways subjects susceptible beta-adrenoceptor blockade calcium antagonist isradipine changes parameters lung function group patients 